Neogen Corp reports results for the quarter ended November 30 - Earnings Summary

• Neogen Corp NEOG.OQ reported quarterly adjusted earnings of 11 cents​​ per share for the quarter ended November 30, identical to the same quarter last year. The mean expectation of four analysts for the quarter was for earnings of 10 cents per share. Wall Street expected results to range from 8 cents to 11 cents per share.

• Revenue rose 0.7% to $231.26 million from a year ago; analysts expected $227.16 million.

• Neogen Corp's reported EPS for the quarter was a loss of $2.10​.

• The company reported a quarterly loss of $456.28 million.

• Neogen Corp shares had risen by 7.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 1.8% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Neogen Corp is $16.50

This summary was machine generated from LSEG data January 10 at 10:50 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)